Following nCRT, CEA expression in tumor tissues increased significantly in comparison to normal tissues (p = 0.003), with T/N ratios ≥ 2 observed in 45.5% of cases (Figure 3B), indicating its potential as a fluorescence-guided imaging target. The gene discussed is CEACAM5; the disease is neoplasm.